Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
NCT ID: NCT01147874
Last Updated: 2012-06-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
1013 participants
INTERVENTIONAL
2010-08-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
NCT01230138
Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
NCT07298265
Effectiveness of a Digital Health Application for Psoriasis
NCT06027034
Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis
NCT03850483
Effect of Long-term Psoriasis on Patients' Life - CORONATE
NCT05555953
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
psoriatic arthritis (PsA) questionnaire
lab draws and imaging
1 set of lab draws, imaging consists of radiographic imaging or X-ray, ultrasound and MRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lab draws and imaging
1 set of lab draws, imaging consists of radiographic imaging or X-ray, ultrasound and MRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has a confirmed diagnosis of plaque psoriasis by clinical judgment.
* Subject is able to read and complete questionnaires.
* Subjects planning to undergo radiographic evaluation, should not have any contraindications to MRI.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Modern Research Assoc. PLLC
Dallas, Texas, United States
Rheumatology Practive of Scott Zashin, MD
Dallas, Texas, United States
Center for Clinical Studies Ltd LLP
Houston, Texas, United States
Rheumatology Associates of Houston
Houston, Texas, United States
Center for Clinical Studies LTD LLP
Webster, Texas, United States
Dermatology Associates
Seattle, Washington, United States
Universitair Ziekenhuis Gent
Ghent, Belgium, Belgium
Algemeen Ziekenhuis St. Jan
Bruges, , Belgium
Kirk Barber Research
Calgary, Alberta, Canada
Stratica Medical
Edmonton, Alberta, Canada
Rheumatology Research Associates
Edmonton, Alberta, Canada
The Skin Care Centre-Clinical Trials Unit
Vancouver, British Columbia, Canada
Winnipeg Clinic
Winnipeg, Manitoba, Canada
Nexus Clinical Research
St. John's, Newfoundland and Labrador, Canada
Dermatrials Research
Hamilton, Ontario, Canada
MAC Research Ind.
Hamilton, Ontario, Canada
K-W Musculoskeletal Research Inc.
Kitchener, Ontario, Canada
Lynderm Research Inc
Markham, Ontario, Canada
The Toronto Western Hospital-Division of Rheumatology
Toronto, Ontario, Canada
K.Papp Clinical Research Inc.
Waterloo, Ontario, Canada
Windsor Clinical Research
Windsor, Ontario, Canada
Medical Office
Windsor, Ontario, Canada
Innovaderm Research Inc
Montreal, Quebec, Canada
Institut de Rheumatologie de Montreal
Montreal, Quebec, Canada
GRMO Inc.
Québec, Quebec, Canada
Centre de Recherche Dermatologique du Quebec metropolitain
Québec, Quebec, Canada
Diex Research Inc.
Sherbrooke, Quebec, Canada
Clinique Medicale Belvedere
Sherbrooke, Quebec, Canada
Hudlaegerne
Arhus C, , Denmark
Bispebjerg University Hospital
Copenhagen NV, , Denmark
Gentofte Hospital
Hellerup, , Denmark
CHU de l Archet
Nice, , France
Hopital Saint Louis
Paris, , France
Hôpital Larrey
Toulouse, , France
Klinik fuer Dermatologie, Allergologie und Venerologie
Berlin, , Germany
Universitaetsklinikum Erlangen Hautklinik im Internistischen Zentrum
Erlangen, , Germany
Klinikum der Johann Wolfgang Goethe Universitaet
Frankfurt am Main, , Germany
Klinik und Poliklinik fuer Dermatologie und
München, , Germany
Praxis Dres. Bredlich, Rosenbach und Thiele
Osnabrück, , Germany
Klinik und Poliklinik fuer Dermatologie
Regensburg, , Germany
Synexus Magyarorszag Kft.
Budapest, , Hungary
Debreceni Egyetem Orvos-és Egészségtudományi Centrum
Debrecen, , Hungary
Borsod Abauj Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz, Szent Ferenc Korhaz Telephely
Miskolc, , Hungary
Miskolci Semmelweis Ignac Egeszsegugyi Kozpont es Egyetemi Oktatokorhaz Nonprofit Kft/Borgyogyaszat
Miskolc, , Hungary
Borgyogyaszati es Allergologiai
Szolnok, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaci D, Behrens F, Northington R, Fuiman J, Bananis E, Boggs R, Alvarez D. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013 Nov;69(5):729-735. doi: 10.1016/j.jaad.2013.07.023. Epub 2013 Aug 24.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B1801032
Identifier Type: -
Identifier Source: secondary_id
0881A6-4728
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.